Cited by 91Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and ResearchDiabetes Treatment and Management

Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data

Open access
Magliano, Dianna J, Chen, Lei, Carstensen, Bendix, Gregg, Edward W, Pavkov, Meda E, Salim, Agus, Andes, Linda J, Balicer, Ran +27 more·2022·The Lancet Diabetes & Endocrinology

Abstract

Background Population-level trends in mortality among people with diabetes are inadequately described. We aimed to examine the magnitude and trends in excess all-cause mortality in people with diabetes.Methods In this retrospective, multicountry analysis, we collected aggregate data from 19 data sources in 16 high-income countries or jurisdictions (in six data sources in Asia, eight in Europe, one from Australia, and four from North America) for the period from Jan 1, 1995, to Dec 31, 2016, (or a subset of this period) on all-cause mortality in people with diagnosed total or type 2 diabetes. We collected data from administrative sources, health insurance records, registries, and a health survey. We estimated excess mortality using the standardised mortality ratio (SMR).Findings In our dataset, there were approximately 21 million deaths during 0·5 billion person-years of follow-up among people with diagnosed diabetes. 17 of 19 data sources showed decreases in the age-standardised and sex-standardised mortality in people with diabetes, among which the annual percentage change in mortality ranged from -0·5% (95% CI -0·7 to -0·3) in Hungary to -4·2% (-4·3 to -4·1) in Hong Kong. The largest decreases in mortality were observed in east and southeast Asia, with a change of -4·2% (95% CI -4·3 to -4·1) in Hong Kong, -4·0% (-4·8 to -3·2) in South Korea, -3·5% (-4·0 to -3·0) in Taiwan, and -3·6% (-4·2 to -2·9) in Singapore. The annual estimated change in SMR between people with and without diabetes ranged from -3·0% (95% CI -3·0 to -2·9; US Medicare) to 1·6% (1·4 to 1·7; Lombardy, Italy). Among the 17 data sources with decreasing mortality among people with diabetes, we found a significant SMR increase in five data sources, no significant SMR change in four data sources, and a significant SMR decrease in eight data sources.Interpretation All-cause mortality in diabetes has decreased in most of the high-income countries we assessed. In eight of 19 data sources analysed, mortality decreased more rapidly in people with diabetes than in those without diabetes. Further longevity gains will require continued improvement in prevention and management of diabetes.Funding US Centers for Disease Control and Prevention, Diabetes Australia Research Program, and Victoria State Government Operational Infrastructure Support Program.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(21)00327-2

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The Swedish National Diabetes Registry revealed a clear improvement of clinical outcomes by each risk factor within the target range (HbA1c, LDL-C, albuminuria, smoking, and SBP).

    “The Swedish National Diabetes Registry revealed a clear improvement of clinical outcomes by each risk factor within the target range (HbA1c, LDL-C, albuminuria, smoking, and SBP).360”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Magliano, D. J., Chen, L., Carstensen, B., Gregg, E. W., Pavkov, M. E., Salim, A., Andes, L. J., Balicer, R., Baviera, M., Chan, J. C. N., Cheng, Y. J., Gardiner, H., Gulseth, H. L., Gurevicius, R., Ha, K. H., Jermendy, G., Kim, D. J., Kiss, Z., Leventer-Roberts, M., Lin, C.-Y., Luk, A. O. Y., Ma, S., Mata-Cases, M., Mauricio, D., Nichols, G. A., Pildava, S., Porath, A., Read, S. H., Robitaille, C., Roncaglioni, M. C., Lopez-Doriga Ruiz, P., Wang, K.-L., Wild, S. H., Yekutiel, N., & Shaw, J. E.
Affiliations
  • Baker Heart and Diabetes Institute (AU)
  • Steno Diabetes Center Copenhagen (DK)
  • Imperial College London (GB)
  • Centers for Disease Control and Prevention (US)
  • Clalit Health Services (IL)
  • Mario Negri Institute for Pharmacological Research (IT)
  • Chinese University of Hong Kong (HK)
  • Norwegian Institute of Public Health (NO)
  • Ajou University (KR)
  • Bajcsy-Zsilinszky Kórház és Rendelőintézet (HU)
  • University of Pecs (HU)
  • Taipei Veterans General Hospital (TW)
  • Ministry of Health (SG)
  • Kaiser Permanente Center for Health Research (US)
  • Ben-Gurion University of the Negev (IL)
  • University of Edinburgh (GB)
  • Public Health Agency of Canada (CA)
  • Maccabi Healthcare Services (IL)
Corresponding author
Magliano, Dianna J
Venue
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Published
2022-02
Volume
10
Issue
2
Pages
112-119
ISSN
2213-8587 (ISSN-L)
OpenAlex
W4205160401
Cited by
91
References
39
Citations by year
2026: 12 · 2025: 16 · 2024: 29 · 2023: 19 · 2022: 15
FWCI
14.64
Type
journal article
Language
en
Open access
Locations
  • The Lancet Diabetes & Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc-nd)
  • NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
  • Figshare (submittedVersion, cc-by)
  • AJOU Open Repository (Ajou University) (submittedVersion)
Funders
  • Diabetes Australia
  • Hospital Authority
  • Istituto di Ricerche Farmacologiche Mario Negri - IRCCS
  • Centers for Disease Control and Prevention (Y18G-MAGD)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
diabetes mellitus, all-cause mortality, excess mortality, mortality trends, type 2 diabetes, standardized mortality ratio, high-income countries, mortality decline, health policy evaluation, Asia, Europe, North America, Australia, South Korea, Hong Kong, Singapore, Taiwan, Medicare, administrative health data, health insurance
MeSH terms
Aged, Diabetes Mellitus, Type 2, Humans, Income, National Health Programs, Registries, Retrospective Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review